DENVER, April 13, 2024 /PRNewswire/ — Experts from NYU Langone’s Department of Neurology present their latest clinical findings and research discoveries…
Browsing: Clinical Trials & Medical Discoveries
Biohaven’s first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at…
Le deuxième essai majeur pour la thérapie de shunt auriculaire démontre l’importance de la sélection des patients TEWKSBURY, Mass., 12…
Zweite große Studie zur Vorhof-Shunt-Therapie zeigt die Bedeutung der Patientenauswahl TEWKSBURY, Massachusetts, 12. April 2024 /PRNewswire/ — Corvia Medical, Inc, ein…
Presentations span Parkinson’s disease and ALS clinical and real-world evidence Oral platform sessions will highlight results from Phase 3 BouNDless…
STOCKHOLM, April 12, 2024 /PRNewswire/ — Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled…
El segundo ensayo importante sobre la terapia de derivación auricular demuestra la importancia de la selección de pacientes TEWKSBURY, Mass.,…
Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, Mass., April 12, 2024 /PRNewswire/ — Corvia…
CLEVELAND, April 11, 2024 /PRNewswire/ — More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud…